William Plovanic
Stock Analyst at Canaccord Genuity
(3.54)
# 822
Out of 5,106 analysts
168
Total ratings
45.33%
Success rate
6.52%
Average return
Main Sectors:
Stocks Rated by William Plovanic
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TNDM Tandem Diabetes Care | Maintains: Buy | $24 → $35 | $22.62 | +54.73% | 7 | Dec 17, 2025 | |
| TMDX TransMedics Group | Maintains: Buy | $147 → $148 | $128.20 | +15.44% | 9 | Dec 17, 2025 | |
| TLSI TriSalus Life Sciences | Maintains: Buy | $11 → $12 | $7.05 | +70.21% | 5 | Dec 17, 2025 | |
| EW Edwards Lifesciences | Maintains: Hold | $89 → $87 | $86.23 | +0.89% | 30 | Dec 17, 2025 | |
| CBLL CeriBell | Maintains: Buy | $29 → $30 | $21.29 | +40.91% | 5 | Dec 17, 2025 | |
| BSX Boston Scientific | Maintains: Buy | $132 → $131 | $96.09 | +36.33% | 13 | Dec 17, 2025 | |
| PODD Insulet | Maintains: Buy | $428 → $432 | $285.50 | +51.31% | 7 | Nov 24, 2025 | |
| HTFL HeartFlow | Maintains: Buy | $39 → $40 | $30.50 | +31.15% | 3 | Nov 13, 2025 | |
| AORT Artivion | Maintains: Buy | $50 → $51 | $47.18 | +8.10% | 4 | Nov 7, 2025 | |
| CVRX CVRx, Inc. | Maintains: Buy | $9 → $11 | $7.61 | +44.55% | 9 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $193 → $212 | $178.60 | +18.70% | 13 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $106 → $99 | $66.86 | +48.07% | 9 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $53 → $64 | $40.54 | +57.87% | 12 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $18 | $13.16 | +36.78% | 8 | Oct 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $7 | $1.43 | +389.51% | 4 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $97 → $90 | $88.77 | +1.39% | 4 | Jul 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $115 → $101 | $89.43 | +12.94% | 3 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $15 | $7.53 | +99.20% | 4 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $284 | $315.95 | -10.11% | 4 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $25 | $21.00 | +19.05% | 1 | Jan 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $12 | $2.22 | +440.54% | 5 | Oct 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $86 → $70 | $87.63 | -20.12% | 4 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $77 → $48 | $23.93 | +100.59% | 5 | Aug 3, 2023 |
Tandem Diabetes Care
Dec 17, 2025
Maintains: Buy
Price Target: $24 → $35
Current: $22.62
Upside: +54.73%
TransMedics Group
Dec 17, 2025
Maintains: Buy
Price Target: $147 → $148
Current: $128.20
Upside: +15.44%
TriSalus Life Sciences
Dec 17, 2025
Maintains: Buy
Price Target: $11 → $12
Current: $7.05
Upside: +70.21%
Edwards Lifesciences
Dec 17, 2025
Maintains: Hold
Price Target: $89 → $87
Current: $86.23
Upside: +0.89%
CeriBell
Dec 17, 2025
Maintains: Buy
Price Target: $29 → $30
Current: $21.29
Upside: +40.91%
Boston Scientific
Dec 17, 2025
Maintains: Buy
Price Target: $132 → $131
Current: $96.09
Upside: +36.33%
Insulet
Nov 24, 2025
Maintains: Buy
Price Target: $428 → $432
Current: $285.50
Upside: +51.31%
HeartFlow
Nov 13, 2025
Maintains: Buy
Price Target: $39 → $40
Current: $30.50
Upside: +31.15%
Artivion
Nov 7, 2025
Maintains: Buy
Price Target: $50 → $51
Current: $47.18
Upside: +8.10%
CVRx, Inc.
Nov 6, 2025
Maintains: Buy
Price Target: $9 → $11
Current: $7.61
Upside: +44.55%
Oct 31, 2025
Maintains: Buy
Price Target: $193 → $212
Current: $178.60
Upside: +18.70%
Oct 31, 2025
Maintains: Buy
Price Target: $106 → $99
Current: $66.86
Upside: +48.07%
Oct 30, 2025
Maintains: Buy
Price Target: $53 → $64
Current: $40.54
Upside: +57.87%
Oct 3, 2025
Maintains: Buy
Price Target: $17 → $18
Current: $13.16
Upside: +36.78%
Aug 6, 2025
Maintains: Buy
Price Target: $8 → $7
Current: $1.43
Upside: +389.51%
Jul 22, 2025
Maintains: Buy
Price Target: $97 → $90
Current: $88.77
Upside: +1.39%
May 12, 2025
Maintains: Hold
Price Target: $115 → $101
Current: $89.43
Upside: +12.94%
Nov 6, 2024
Maintains: Buy
Price Target: $12 → $15
Current: $7.53
Upside: +99.20%
Feb 23, 2024
Reiterates: Buy
Price Target: $284
Current: $315.95
Upside: -10.11%
Jan 22, 2024
Maintains: Buy
Price Target: $22 → $25
Current: $21.00
Upside: +19.05%
Oct 31, 2023
Maintains: Buy
Price Target: $20 → $12
Current: $2.22
Upside: +440.54%
Aug 28, 2023
Maintains: Hold
Price Target: $86 → $70
Current: $87.63
Upside: -20.12%
Aug 3, 2023
Downgrades: Hold
Price Target: $77 → $48
Current: $23.93
Upside: +100.59%